Filtros de búsqueda

Lista de obras de Charlotte Teunissen

24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis

artículo científico publicado en 2007

A Practical Guide to Immunoassay Method Validation

artículo científico publicado en 2015

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

scientific article published on 18 December 2019

A more randomly organized grey matter network is associated with deteriorating language and global cognition in individuals with subjective cognitive decline.

artículo científico publicado en 2018

A multi-center study of neurofilament assay reliability and inter-laboratory variability

artículo científico publicado en 2020

A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging

artículo científico publicado en 2017

A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease

artículo científico publicado en 2017

A prediction model to calculate probability of Alzheimer's disease using cerebrospinal fluid biomarkers

artículo científico publicado en 2012

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease

artículo científico publicado en 2020

ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project

artículo científico publicado en 2020

Age‐ and disease‐specific reference values for neurofilament light presented in an online interactive support interface

artículo científico publicado en 2022

Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard

artículo científico publicado en 2013

Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal.

artículo científico publicado en 2019

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design

artículo científico publicado en 2017

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

artículo científico publicado en 2015

Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment

artículo científico publicado en 2017

Amyloid-β PET and CSF in an autopsy-confirmed cohort

artículo científico publicado en 2020

Amyloid-β oligomers relate to cognitive decline in Alzheimer's disease

artículo científico publicado en 2015

An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels.

artículo científico publicado en 2009

An update on the genetics of dementia with Lewy bodies

artículo científico publicado en 2017

Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy

artículo científico publicado en 2015

Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly

artículo científico publicado en 2016

Applying the ATN scheme in a memory clinic population: The ABIDE project

scientific article published on 09 October 2019

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia

artículo científico publicado en 2017

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease

artículo científico publicado en 2017

Association of amyloid pathology with memory performance and cognitive complaints in cognitively normal older adults: a monozygotic twin study

artículo científico publicado en 2019

Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers

artículo científico publicado en 2014

Associations of AD Biomarkers and Cognitive Performance with Nutritional Status: The NUDAD Project.

artículo científico publicado en 2019

Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline

artículo científico publicado en 2018

Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression

artículo científico publicado en 2019

BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease

artículo científico publicado en 2014

Biobanking of CSF: international standardization to optimize biomarker development

artículo científico

Biobanking of Cerebrospinal Fluid for Biomarker Analysis in Neurological Diseases

artículo científico

Biomarker report from the phase II lamotrigine trial in secondary progressive MS - neurofilament as a surrogate of disease progression

artículo científico publicado en 2013

Biomarker research in multiple sclerosis: addressing axonal damage and heterogeneity

artículo científico publicado en 2007

Biomarker testing in MCI patients-deciding who to test

artículo científico publicado en 2021

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

scientific article published on 13 September 2019

Blood-based metabolic signatures in Alzheimer's disease

artículo científico publicado en 2017

Body fluid biomarkers for multiple sclerosis--the long road to clinical application

artículo científico

Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and CSF biomarkers

artículo científico publicado en 2013

Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and CSF biomarkers

scholarly article by Maja Binnewijzend et al published July 2013 in Alzheimer's and Dementia

Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and cerebrospinal fluid biomarkers

scholarly article by Maja Binnewijzend et al published July 2013 in Alzheimer's and Dementia

Building a new paradigm for the early recognition of behavioral variant frontotemporal dementia: Late Onset Frontal Lobe Syndrome study

artículo científico publicado en 2013

CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease

scientific article published on 01 January 2020

CDH6 and HAGH protein levels in plasma associate with Alzheimer's disease in APOE ε4 carriers

scientific article published on 19 May 2020

CNS penetration of ART in HIV-infected children

artículo científico publicado en 2017

CSF AMYLOID BETA 1-42 LEVELS OBTAINED OVER 15 YEARS SHOW A DIAGNOSIS-DEPENDENT UPWARD DRIFT

CSF ApoE predicts clinical progression in nondemented APOEε4 carriers

artículo científico publicado en 2017

CSF biomarker variability in the Alzheimer's Association quality control program

artículo científico publicado en 2013

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

artículo científico publicado en 2012

CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls

artículo científico publicado en 2007

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?

artículo científico publicado en 2015

Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions

scientific article published on 09 August 2019

Cerebral perfusion in the predementia stages of Alzheimer's disease

artículo científico publicado en 2015

Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort

artículo científico publicado en 2016

Cerebrospinal Fluid Amyloid-β Subtypes in Confirmed Frontotemporal Lobar Degeneration Cases: A Pilot Study

artículo científico publicado en 2019

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints

artículo científico publicado en 2012

Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort

artículo científico publicado en 2015

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

artículo científico publicado en 2017

Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease

artículo científico publicado en 2013

Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis

artículo científico publicado en 2008

Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis

artículo científico publicado en 2012

Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables

artículo científico publicado en 2014

Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders

artículo científico publicado en 2017

Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease

artículo científico publicado en 2015

Cerebrospinal fluid biomarkers in multiple sclerosis

artículo científico publicado en 2009

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

artículo científico publicado en 2008

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

artículo científico publicado en 2019

Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes

artículo científico publicado en 2014

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

artículo científico publicado en 2014

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

artículo científico publicado en 2011

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment.

artículo científico publicado en 2017

Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease

artículo científico publicado en 2020

Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases

artículo científico

Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes

artículo científico publicado en 2015

Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies

artículo científico publicado en 2018

Circulating metabolites are associated with brain atrophy and white matter hyperintensities

artículo científico publicado en 2020

Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types

artículo científico publicado en 2011

Clinical phenotype, atrophy, and small vessel disease in ε2 carriers with Alzheimer disease

artículo científico publicado en 2018

Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.

artículo científico publicado en 2018

Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts

artículo científico publicado en 2017

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

artículo científico publicado en 2009

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

artículo científico publicado en 2020

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

artículo científico publicado en 2016

Comparison of multiplex platforms for cytokine assessments and their potential use for biomarker profiling in multiple sclerosis

artículo científico publicado en 2017

Computer-assisted prediction of clinical progression in the earliest stages of AD

scientific article published on 08 October 2018

Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies

artículo científico publicado en 2016

Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort

artículo científico publicado en 2014

Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies

artículo científico publicado en 2011

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

artículo científico publicado en 2013

Consensus guidelines for lumbar puncture in patients with neurological diseases

artículo científico publicado en 2017

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease.

artículo científico publicado en 2018

Contactins in the central nervous system: role in health and disease

article

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

artículo científico publicado en 2015

Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease

artículo científico publicado en 2015

Corrigendum to “Standard biobanking conditions prevent evaporation of body fluid samples” Clinica Chimica Acta 442 (2015) 141–145

scholarly article published in Clinica Chimica Acta

Current Approaches and Clinician Attitudes to the Use of Cerebrospinal Fluid Biomarkers in Diagnostic Evaluation of Dementia in Europe

artículo científico publicado en 2017

Data-Driven Differential Diagnosis of Dementia Using Multiclass Disease State Index Classifier.

artículo científico publicado en 2018

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease

scholarly article by Rosha Babapour Mofrad et al published December 2019 in Alzheimer's & dementia (Amsterdam, Netherlands)

Degree of genetic liability for Alzheimer's disease associated with specific proteomic profiles in cerebrospinal fluid

scientific article published on 24 March 2020

Design of the ExCersion-VCI study: The effect of aerobic exercise on cerebral perfusion in patients with vascular cognitive impairment

artículo científico publicado en 2017

Design of the NL-ENIGMA study: Exploring the effect of Souvenaid on cerebral glucose metabolism in early Alzheimer's disease

artículo científico publicado en 2016

Detection of contactin-2 in cerebrospinal fluid (CSF) of patients with Alzheimer's disease using Fluorescence Correlation Spectroscopy (FCS).

artículo científico publicado en 2017

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

artículo científico publicado en 2019

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach

artículo científico publicado en 2010

Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic

artículo científico publicado en 2014

Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project

scholarly article by Eline A J Willemse et al published 2018 in Alzheimer's & dementia (Amsterdam, Netherlands)

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration

artículo científico publicado en 2020

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

artículo científico publicado en 2020

Differential Expression of Tissue Transglutaminase Splice Variants in Peripheral Blood Mononuclear Cells of Primary Progressive Multiple Sclerosis Patients

Differential effects of cognitive reserve and brain reserve on cognition in Alzheimer disease

artículo científico publicado en 2017

Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.

artículo científico publicado en 2012

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

artículo científico publicado en 2019

Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes

artículo científico publicado en 2015

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study

artículo científico publicado en 2012

Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change

scholarly article by Lianne M. Reus et al published September 2018 in Journal of Psychiatric Research

Disease-related determinants are associated with mortality in dementia due to Alzheimer's disease

artículo científico publicado en 2018

EFNS guidelines on disease-specific CSF investigations

artículo científico publicado en 2009

Early onset Alzheimer's disease is associated with a distinct neuropsychological profile

artículo científico publicado en 2012

Effect of long-term storage in biobanks on cerebrospinal fluid biomarker Aβ1-42, T-tau, and P-tau values

artículo científico publicado en 2017

Facilitating the Validation of Novel Protein Biomarkers for Dementia: An Optimal Workflow for the Development of Sandwich Immunoassays

artículo científico publicado en 2015

Fluid biomarkers for disease activity in multiple sclerosis

artículo científico publicado en 2017

GREY MATTER CONNECTIVITY IS ASSOCIATED WITH TIME TO CLINICAL PROGRESSION IN MILD COGNITIVE IMPAIRMENT, INDEPENDENT OF AMYLOID STATUS

article by Betty M Tijms et al published July 2016 in Alzheimer's and Dementia

Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

artículo científico publicado en 2020

Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients

artículo científico publicado en 2017

Gray matter network differences between behavioral variant frontotemporal dementia and Alzheimer's disease

artículo científico publicado en 2016

Gray matter network measures are associated with cognitive decline in mild cognitive impairment

artículo científico publicado en 2017

Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease

artículo científico publicado en 2017

Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders

artículo científico publicado en 2014

Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease

artículo científico publicado en 2016

Homocysteine in relation to cognitive performance in pathological and non-pathological conditions

artículo científico publicado en 2005

How to handle adsorption of cerebrospinal fluid amyloid β (1-42) in laboratory practice? Identifying problematic handlings and resolving the issue by use of the Aβ42/Aβ40 ratio

artículo científico publicado en 2017

Hypometabolism of the posterior cingulate cortex is not restricted to Alzheimer's disease.

artículo científico publicado en 2018

Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach

scientific article published on 18 June 2020

Impact of Imaging and Cerebrospinal Fluid Biomarkers on Behavioral Variant Frontotemporal Dementia Diagnosis within a Late-Onset Frontal Lobe Syndrome Cohort.

artículo científico publicado en 2015

Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes

artículo científico publicado en 2017

In vivo detection of myelin proteins in cervical lymph nodes of MS patients using ultrasound-guided fine-needle aspiration cytology

artículo científico publicado en 2005

Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriers

artículo científico publicado en 2013

Inflammatory and Neuronal Biomarkers Associated With Retinal Thinning in Pediatric HIV.

artículo científico publicado en 2017

Inflammatory biomarkers in Alzheimer's disease plasma.

artículo científico publicado en 2019

Influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease

artículo científico publicado en 2014

Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease

artículo científico publicado en 2012

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

artículo científico publicado en 2012

Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers

artículo científico publicado en 2015

Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer's disease

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project

artículo científico publicado en 2017

Iron and neurodegeneration in multiple sclerosis

artículo científico publicado en 2011

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?

artículo científico publicado en 2019

Konsensusprotokoll zur Standardisierung von Entnahme und Biobanking des Liquor cerebrospinalis 1 / A consensus protocol for the standardisation of cerebrospinal fluid collection and biobanking

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

scientific article published on 06 April 2019

Low normal cerebrospinal fluid Aβ42 levels predict clinical progression in nondemented subjects

artículo científico publicado en 2017

Lumbar puncture in patients with neurologic conditions

artículo científico publicado en 2017

Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status

artículo científico publicado en 2013

Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds

artículo científico publicado en 2015

Maximizing the Potential of Longitudinal Cohorts for Research in Neurodegenerative Diseases: A Community Perspective

artículo científico publicado en 2017

Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study

artículo científico publicado en 2017

Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.

artículo científico publicado en 2011

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression

artículo científico publicado en 2015

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab

artículo científico publicado en 2020

Monocyte-derived tissue transglutaminase in multiple sclerosis patients: reflecting an anti-inflammatory status and function of the cells?

artículo científico publicado en 2017

Multi-tracer model for staging cortical amyloid deposition using PET imaging

artículo científico publicado en 2020

Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration

artículo científico publicado en 2016

N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis

artículo científico publicado en 2014

N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry

artículo científico publicado en 2007

Neurofilament ELISA validation.

artículo científico publicado en 2009

Neurofilament light chain and glial fibrillary acidic protein levels in metachromatic leukodystrophy

artículo científico publicado en 2022

Neurofilament light chain: a biomarker for genetic frontotemporal dementia

scientific article published on July 2016

Neurofilament stoichiometry simulations during neurodegeneration suggest a remarkable self-sufficient and stable in vivo protein structure

artículo científico publicado en 2011

Neurofilaments as biomarkers in multiple sclerosis

artículo científico

Neurofilaments as biomarkers in neurological disorders

article by Michael Khalil et al published 31 August 2018 in Nature Reviews Neurology

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.

artículo científico publicado en 2018

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

artículo científico publicado en 2015

New CSF biomarkers on the block

artículo científico publicado en 2016

No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients

scholarly article by Claire Bridel published in January 2018

Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization

artículo científico publicado en 2016

Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency

artículo científico publicado en 2010

Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics.

artículo científico publicado en 2016

Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia

artículo científico publicado en 2017

Nutritional status and structural brain changes in Alzheimer's disease: The NUDAD project

artículo científico publicado en 2020

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease

artículo científico publicado en 2016

Optimizing patient care and research: the Amsterdam Dementia Cohort

artículo científico publicado en 2014

Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis

artículo científico publicado en 2013

Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study

artículo científico publicado en 2015

Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project

Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes

artículo científico publicado en 2018

Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease.

artículo científico publicado en 2018

Plasma proteome in multiple sclerosis disease progression

artículo científico publicado en 2019

Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers.

artículo científico publicado en 2018

Pre-amyloid stage of Alzheimer's disease in cognitively normal individuals

scholarly article by Betty M Tijms et al published September 2018 in Annals of clinical and translational neurology

Preclinical AD predicts decline in memory and executive functions in subjective complaints

artículo científico publicado en 2013

Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers

artículo científico publicado en 2017

Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics

artículo científico publicado en 2015

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

artículo científico publicado en 2013

Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples

scholarly article by Steffen Wolfsgruber et al published 17 January 2019 in Alzheimers Research & Therapy

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

artículo científico publicado en 2015

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

artículo científico publicado en 2018

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

scientific article published on 08 May 2019

Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset

artículo científico publicado en 2019

Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis

artículo científico publicado en 2007

Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset

artículo científico publicado en 2014

Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update

artículo científico publicado en 2012

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

artículo científico

Regulator of oligodendrocyte maturation, miR-219, a potential biomarker for MS.

artículo científico publicado en 2017

Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition

artículo científico publicado en 2017

Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study

Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.

artículo científico publicado en 2019

Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.

artículo científico

Role of BRI2 in dementia

artículo científico

SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease

artículo científico publicado en 2014

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study

scholarly article by Philip Scheltens et al published 12 October 2018 in Alzheimers Research & Therapy

Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy

scientific article published on 15 January 2020

Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study

artículo científico publicado en 2017

Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers

artículo científico publicado en 2011

Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease

artículo científico publicado en 2015

Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

artículo científico publicado en 2019

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

artículo científico publicado en 2015

Sex differences in CSF biomarkers vary by Alzheimer's disease stage and APOE ε4 genotype

artículo científico publicado en 2020

Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease-Data from three memory clinic studies

artículo científico publicado en 2018

Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid

artículo científico publicado en 2016

Standard biobanking conditions prevent evaporation of body fluid samples

artículo científico publicado en 2015

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop

artículo científico publicado en 2010

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

artículo científico publicado en 2011

Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease.

artículo científico publicado en 2018

Systemic and intrathecal immune activation in association with cerebral and cognitive outcomes in paediatric HIV

scientific article published on 29 May 2019

Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.

artículo científico publicado en 2016

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid

artículo científico publicado en 2015

Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.

artículo científico publicado en 2012

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

artículo científico publicado en 2011

The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases

artículo científico publicado en 2015

The Dutch Parelsnoer Institute--Neurodegenerative diseases; methods, design and baseline results

artículo científico publicado en 2014

The EMIF-AD PreclinAD study: study design and baseline cohort overview

article by Elles Konijnenberg et al published 4 August 2018 in Alzheimers Research & Therapy

The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease

artículo científico publicado en 2014

The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?

artículo científico publicado en 2014

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative

artículo científico publicado en 2014

The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme

artículo científico publicado en 2013

The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis

artículo científico publicado en 2015

The impact of pre-analytical variables on the stability of neurofilament proteins in CSF, determined by a novel validated SinglePlex Luminex assay and ELISA.

artículo científico publicado en 2013

The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

scientific article published on 23 June 2018

The inflammatory marker GDF-15 is not independently associated with late-life depression

artículo científico publicado en 2016

The metabolic syndrome in a memory clinic population: relation with clinical profile and prognosis

artículo científico publicado en 2015

The plasma peptides of ovarian cancer

scholarly article by Jaimie Dufresne et al published 2018 in Clinical Proteomics

The plasma peptidome

scholarly article by Jaimie Dufresne published in January 2018

Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results

artículo científico publicado en 2017

Unbiased estimates of cerebrospinal fluid β-amyloid 1-42 cutoffs in a large memory clinic population

artículo científico publicado en 2017

Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years

artículo científico publicado en 2017

Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study

artículo científico publicado en 2015

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

scientific article published on 01 January 2020

Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases

artículo científico publicado en 2016

Variability of CSF Alzheimer's disease biomarkers: implications for clinical practice

artículos científicos

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.

artículo científico publicado en 2018

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.

artículo científico publicado en 2018

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases

artículo científico publicado en 2010

gMS-Classifier1 does not predict disability progression in multiple sclerosis.

artículo científico publicado en 2018

α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies

scholarly article by Inger van Steenoven et al published November 2018 in Movement Disorders

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda